Oura to acquire AI-native primary care startup Counsel Health for $625M

Oura has agreed to acquire Counsel Health, an AI-native primary care startup, for $625 million, according to a TechCrunch report published on November 10 that lays out both the price and the context around it.

The timing is the story. The deal was announced a few weeks after Oura postponed an IPO of up to $2.2 billion indefinitely, citing uncertainty in the IPO market. Having paused at the door of the public markets, the company is instead pushing its business forward through acquisition.

Counsel Health sits in AI-native primary care, meaning AI is built into the core of the care process rather than bolted on as an efficiency tool. Companies in that category aim to handle routine consultations, follow-ups and ongoing health management in software, reserving human attention for the decisions that actually need judgment.

Oura's own core asset is the continuous physiological data its wearables collect over time, spanning measures such as sleep and heart rate. The logic of the combination is that hardware supplies a steady stream of signals while AI-driven primary care supplies interpretation and intervention. Neither half is a complete product on its own.

That is also why an acquisition may say more about direction than an IPO would. Going public brings capital and visibility, but it does not conjure a care delivery business. Buying a team that has already built AI-native clinical workflows is a faster way to add the service layer.

The $625 million price puts Oura on the same table as other AI healthcare acquirers. Wearable makers have competed mainly on data capture; the contest is shifting toward who can turn that data into actionable health guidance, a capability that is hard to build entirely in-house.

Three things to watch: whether the deal clears regulatory review, how Counsel Health's team and products are folded into Oura's existing health services, and whether the postponed IPO returns once market conditions improve. Progress on any of them will shape how the price is judged.